Skip to NavigationSkip to content

Merck appoints UK leadership team

Published on: 26/01/10

Merck & Co’s UK business has unveiled its new leadership team, following last year’s merger with Schering-Plough.

Merck Sharp & Dohme’s Human Health Leadership Team appointments are:

Haseeb Ahmad - director of strategy

Keith Bousfield - director of primary care marketing

David Hewitt - director of consumer health

Jim Page - immunology business unit director

Kevin Peters - director of business operations

Chris Ponty - specialty business unit director

Kate Tillett - director of external affairs

Sally-Anne Tsangarides - hospital business unit director

Ilse van Roy - women's health business unit director

Craig Wallace - primary care sales director

Tim Williams - director of market access

UK managing director Deepak Khanna said: "The outline shape for our organisation in the UK combines the strengths of both legacy companies.

"At the heart of our organisation is our aspiration to be viewed by the NHS as their most trusted and valued healthcare partner, and to make a substantial difference to patients."

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches